Celebrity-backed cancer treatment venture eyes London listing
A cancer drug venture backed by a group of celebrity investors and Middle Eastern wealth is planning to list on the London Stock Exchange. Ellipses Pharma, a clinical-stage oncology venture founded by renowned British biotech entrepreneur Sir Chris Evans and, is preparing to reverse into a brand-new company, targeting a listing valuation of between £450m [...]
We haven't written up this one. City AM has the full story — the link below goes straight to it.